Sponsored By:
|

Author: Thomas Maeder
Biopharmaceutical Manufacturing
- Given the financial realities in the pharmaceutical industry today, there is intensifying pressure to decrease time to market and raise productivity, while containing costs for both facilities and R&D staff.
Publisher: Contractpharma.com
Author: Jim Wilkins
Biotech, Medical Device Companies Encounter Prop. 65
- It began as a routine merger. An established Southern California biotechnology company was acquiring a smaller firm to expand its capabilities and reach. The new company would immediately become a world leader in its field. A crucial detail interrupted the process, however: Proposition 65.
Publisher: Brobeck, Phleger & Harrison
Author: John E. Carlson ; Mary L. Walker ; Kenneth L. Waggoner
Design and Commissioning Of a Contract API Facility
- When we decided to enter the Active Pharmaceutical Ingredient (API) market, we embarked on the planning and implementation process to provide a “best in class” manufacturing facility in full compliance with current good manufacturing practices (cGMP).
Publisher: Contractpharma.com
Author: Ralph Tyree
[
Next 10 Publications ]
|